tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

FBIO Stock Latest News

Fortress Biotech price target raised to $24 from $10 at H.C. Wainwright
The FlyFortress Biotech price target raised to $24 from $10 at H.C. Wainwright
15d ago
FBIO
Fortress Biotech reports FY23 EPS ($8.47) vs. ($15.97) last year
PremiumThe Fly
Fortress Biotech reports FY23 EPS ($8.47) vs. ($15.97) last year
27d ago
FBIO
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
PremiumPress Releases
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
27d ago
FBIO
Fortress Biotech Inc (FBIO) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Fortress Biotech Inc (FBIO) Q4 Earnings Cheat Sheet
1M ago
FBIO
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
PremiumPress Releases
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
1M ago
CKPT
FBIO
Fortress Biotech initiated with a Buy at Alliance Global Partners
PremiumThe FlyFortress Biotech initiated with a Buy at Alliance Global Partners
1M ago
FBIO
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
PremiumPress Releases
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
1M ago
DERM
FBIO
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
PremiumPress Releases
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
1M ago
DERM
FBIO
Fortress Biotech resumed with a Buy at Roth MKM
PremiumThe Fly
Fortress Biotech resumed with a Buy at Roth MKM
1M ago
FBIO
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
PremiumPress Releases
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
1M ago
DERM
FBIO
Fortress Biotech to Participate in 36th Annual ROTH Conference
PremiumPress Releases
Fortress Biotech to Participate in 36th Annual ROTH Conference
1M ago
FBIO
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
PremiumPress Releases
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
1M ago
DERM
FBIO
Fortress Biotech, Cyprium Therapeutics announces $4.1M grant from NINDS
PremiumThe FlyFortress Biotech, Cyprium Therapeutics announces $4.1M grant from NINDS
2M ago
FBIO
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
PremiumPress Releases
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
2M ago
FBIO
Fortress Biotech Announces Eric Rowinsky’s Board Departure
PremiumMarket News
Fortress Biotech Announces Eric Rowinsky’s Board Departure
3M ago
8K
FBIO
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
PremiumPress Releases
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
4M ago
DERM
FBIO
Fortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PremiumPress Releases
Fortress Biotech Announces Closing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4M ago
FBIO
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
PremiumPress Releases
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
4M ago
DERM
FBIO
Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PremiumPress Releases
Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4M ago
FBIO
Fortress Biotech prices 3.3M shares at $3.33 in registered direct offering
PremiumThe FlyFortress Biotech prices 3.3M shares at $3.33 in registered direct offering
4M ago
FBIO
Fortress’ Cyprium executed an Assignment, Assumption Agreement with Sentynl
PremiumThe Fly
Fortress’ Cyprium executed an Assignment, Assumption Agreement with Sentynl
5M ago
FBIO
Cyprium Therapeutics, a Fortress Biotech Subsidiary Company, Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease, to Sentynl Therapeutics, a Wholly-owned Subsidiary of Zydus Lifesciences Ltd.
PremiumPress Releases
Cyprium Therapeutics, a Fortress Biotech Subsidiary Company, Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease, to Sentynl Therapeutics, a Wholly-owned Subsidiary of Zydus Lifesciences Ltd.
5M ago
FBIO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >